Advanced Bifurcation Systems Announces Livermore Global Manufacturing Center
Published: Aug 21, 2018
Los Angeles, California, August 21, 2018 - Medical device manufacturer, Advanced Bifurcation Systems® announced today that it has selected a facility in Livermore California for its first manufacturing facility. Charles Laverty announced in an interview from ABS’ Southern California headquarters that it expects to certify the facility to manufacture the company’s products and that this is a critical step towards planned application for review by the US Food and Drug Administration.
The Livermore location has Class 10,000 Cleanrooms which will be certified to build and assemble the ABS mother-daughter system. Laverty states that the ABS approach allows for more precise placement of stents, reducing failures and allowing for placement in bifurcations.
Laverty has been an advocate for more medical innovation, particularly to address major, global health problems including the worldwide growth in heart disease. He writes on his blog that the company says that experts estimate the total coronary stent market will reach $10B in 2025 and bifurcation disease could be 25% of that.
Advanced Bifurcation Systems was co-founded by Interventionist Cardiologist, Dr. Mehran Khorsandi of Cedars-Sinai Medical Center and Henry Bourang who serves as Chief Technical Officer and has amassed over 100 patents. The company expects to have fifty international patents awarded soon, having already been awarded thirty-six in 5 countries.
The company began a $20M fundraising round and has closed multiple tranches of that funding. Last month it announced a partnership with The Family Office Network who will be hosting a series of events highlighting ABS.
Advanced Bifurcation Systems
Chief Executive Officer